Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice-Reference-Cited by-同舟云学术

Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice

Published:2012-02-01 Issue:2 Volume:122 Page:639-653
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Collins Meredith A.,Bednar Filip,Zhang Yaqing,Brisset Jean-Christophe,Galbán Stefanie,Galbán Craig J.,Rakshit Sabita,Flannagan Karen S.,Adsay N. Volkan,Pasca di Magliano Marina

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference68 articles.

1. Patterns of Recurrence After Curative Resection of Pancreatic Cancer, Based on Autopsy Findings

2. Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

3. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Cited by 645 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming therapy resistance in pancreatic cancer: New insights and future directions;Biochemical Pharmacology;2024-11

2. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

3. Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation;Cell Reports Medicine;2024-09

4. Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer;Cancer Cell;2024-09

5. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles;Frontiers in Immunology;2024-08-30